Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxalidine with propofol for painless gastrointestinal endoscopy in elderly patients
ChiCTR2500095332Phase 4Not yet recruiting
- Sponsor
- Guangzhou Panyu District Central Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in gastrointestinal conditions (3 arms), sponsored by Guangzhou Panyu District Central Hospital. Primary endpoints: Incidence of hypoxemia and Incidence of body movement. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2500095332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095332.